APTABIO THERAPEUTICS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,650 KRW | -2.42% |
|
-5.68% | -37.57% |
| Sales 2022 | 48.35M 35.1K | Sales 2023 | 324M 235K | Capitalization | 202B 147M |
|---|---|---|---|---|---|
| Net income 2022 | -10.56B -7.67M | Net income 2023 | -19.1B -13.87M | EV / Sales 2022 | 4,567 x |
| Net cash position 2022 | 16.65B 12.09M | Net cash position 2023 | 38.95B 28.28M | EV / Sales 2023 | 503 x |
| P/E ratio 2022 |
-22.5
x | P/E ratio 2023 |
-10.7
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.49% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.42% | ||
| 1 week | -5.68% | ||
| Current month | -19.40% | ||
| 1 month | -12.40% | ||
| 3 months | -21.09% | ||
| 6 months | -29.73% | ||
| Current year | -37.57% |
1 week
5 630.00
6 120.00
1 month
5 600.007 530.00
Current year
4 935.009 520.00
1 year
4 935.0013 330.00
3 years
4 935.0062 100.00
5 years
4 935.0062 100.00
10 years
4 935.0062 100.00
| Managers | Title | Age | Since |
|---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 09-07-23 |
Sung-Hwan Moon
PSD | President | 65 | - |
Jun-Hee Jung
DFI | Director of Finance/CFO | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 09-07-23 |
Jong-Nam Suh
BRD | Director/Board Member | 62 | - |
Sung-Hwan Moon
PSD | President | 65 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 5,650 | -2.42% | 27 789 |
| 24-04-25 | 5,790 | -1.53% | 15,779 |
| 24-04-24 | 5,880 | +0.51% | 24,743 |
| 24-04-23 | 5,850 | -0.85% | 23,659 |
| 24-04-22 | 5,900 | +2.08% | 31,653 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
Aptabio Therapeutics Inc. is a Korea-based company that researches and develops new drugs. The Company is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -37.57% | 94.01M | |
| -1.92% | 103B | |
| +0.47% | 95.71B | |
| +1.69% | 22.02B | |
| -17.39% | 20.9B | |
| -9.30% | 17.85B | |
| -41.01% | 16.21B | |
| -14.77% | 15.52B | |
| +3.47% | 13.86B | |
| +35.28% | 12.04B |
- Stock Market
- Equities
- A293780 Stock
